Clinical Trial Update: Safety of Juvista When Administered Following Excision of Ear Lobe Keloids [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating the safety of Juvista when administered after excision of ear lobe keloids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid

Drugs mentioned

• Juvista (avotermin)

Snippet

Sponsor: Renovo | Conditions: Keloid | Phase 1, Phase 2 | Status: COMPLETED